Ken Griffin Franklin Templeton ETF Tr Geno Transaction History

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Franklin Templeton ETF Tr Geno stock. As of the latest transaction made, Citadel Advisors LLC holds 7,966 shares of HELX stock, worth $250,849. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,966
Holding current value
$250,849
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
N/A
7,966 New
7,966 $250,000
Q1 2024

May 15, 2024
BUY
$29.38 - $32.86 $325,295 - $363,825
11,072 New
11,072 $362,000

Others Institutions Holding HELX

# of Institutions
11
Shares Held
103K
Call Options Held
0
Put Options Held
0
View Full List

About FRANKLIN TEMPLETON ETF TR GENO

HELX Quotes by TradingView
  • Ticker HELX
  • Sector ETFs
  • Industry ETFs
More about HELX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email